College of Public Health and Human Sciences

D. B. Jump, Lytle, K. A., Depner, C. M., and Tripathy, S., “Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.”, Pharmacol Ther, vol. 181, pp. 108-125, 2018.

D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.”, Proc Nutr Soc, vol. 75, no. 1, pp. 1-9, 2016.

K. A. Lytle and Jump, D. B., “Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?”, PLoS One, vol. 11, no. 1, p. e0146942, 2016.

K. A. Lytle, Depner, C. M., Wong, C. P., and Jump, D. B., “Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.”, J Lipid Res, vol. 56, no. 10, pp. 1936-46, 2015.

D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.”, Advances in nutrition (Bethesda, Md.), vol. 6, no. 6, pp. 694-702, 2015.

S. Tripathy, Lytle, K. A., Stevens, R. D., Bain, J. R., Newgard, C. B., Greenberg, A. S., Huang, L. - S., and Jump, D. B., “Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.”, Journal of lipid research, vol. 55, no. 7, pp. 1448-1464, 2014.